DJ
Davis Jerel

Davis Jerel insider trades: Turnstone Biologics (TSBX) stock buys and sales

Turnstone Biologics Last trade Jul 25, 2023 34 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2020
4
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Davis reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 25, 2023TSBX↑ Buy$2.4M
Jul 25, 2023TSBX↑ Buy$180K
Jul 25, 2023TSBX↑ Buy$79K
Jul 25, 2023TSBX↑ Buy$71K
Apr 17, 2023KDNY↓ Sell$6.1M
Mar 1, 2023KDNY↓ Sell$9.1M
Dec 9, 2022RPTX↓ Sell$4.0M
Jun 3, 2022RPTX↓ Sell$9.2M
Jan 3, 2022KDNY↓ Sell$16.0M
Aug 27, 2021KDNY↓ Sell$11.9M
Jun 29, 2021GRPH↑ Buy$3.1M
Jun 23, 2020RPTX↑ Buy$5.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Davis Jerel's insider trades

Davis Jerel is an insider at Turnstone Biologics (TSBX). Since Jun 23, 2020, Davis has reported 6 open-market purchases worth $10.8M and 6 sales worth $56.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include other transactions (14 filings), grants and awards (10 filings), conversions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TSBX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.